TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
NYSE · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Jun 17, 2026
$17,86
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$12,99rendah 52m
$19,10tinggi 52m
P/E
-0.2
EPS
$-96.75
Pendapatan
$4.51T
lencana Anda
Rentang 52M
$13–$19
Peringkat Analis
BUY
Target Harga
$22
P/E
-0.2
ROE
-2.1%
Margin Laba Bersih
-3.4%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
TAK Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$17.86
P/E
-0.2
EPS
$-96.75
Pendapatan
$4.51T
ROE
-2.1%
Rentang 52M
$13–$19
TAK Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$4.51T2017-03-31 → 2026-03-31
EPS$-96.752017-03-31 → 2026-03-31
Arus Kas Bebas$865.43B2019-03-31 → 2026-03-31
Margin bersih-3.4%2019-03-31 → 2026-03-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | TAK | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -0.2rata-rata 5T ≈0.1 | ≈0.1 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | TAK | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | 0.14%rata-rata 5T ≈7.5% | ≈7.5% | · | · | |
| EBITDA Margin (Margin EBITDA) | 16.1%rata-rata 5T ≈24.1% | ≈24.1% | · | · | |
| Pretax Margin (Margin Sebelum Pajak) | -3.2%rata-rata 5T ≈3.9% | ≈3.9% | · | · | |
| Net Profit Margin (Margin Laba Bersih) | -3.4%rata-rata 5T ≈3.3% | ≈3.3% | · | · | |
| ROA | -1.0%rata-rata 5T ≈0.96% | ≈0.96% | · | · | |
| ROE | -2.1%rata-rata 5T ≈2.2% | ≈2.2% | · | · | |
| ROIC | 0.09%rata-rata 5T ≈4.8% | ≈4.8% | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | TAK | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Current Ratio (Rasio Lancar) | 1.1rata-rata 5T ≈1.1 | ≈1.1 | · | · | |
| Quick Ratio (Rasio Cepat) | 0.3rata-rata 5T ≈0.4 | ≈0.4 | · | · | |
| Interest Coverage (Cakupan Bunga) | 0.0rata-rata 5T ≈2.5 | ≈2.5 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | TAK | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.3rata-rata 5T ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Perputaran Persediaan) | 1.2rata-rata 5T ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover (Perputaran Piutang) | 5.8rata-rata 5T ≈5.9 | ≈5.9 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$95.8M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Rasio Pembayaran Dividen-204.7%
Pembayaran Tahunan≈$0.68
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Mar 31, 2025 | $0,34 | USD | ≈4.5% |
| Sep 30, 2024 | $0,33 | USD | ≈4.3% |
| Mar 27, 2024 | $0,29 | USD | ≈2.1% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
9.1%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | $70.54 | $54.92 | 28.4% | |
| 31 Maret 2026 | $-15.56 | $-24.26 | 35.8% | |
| 31 Des. 2025 | $65.65 | $34.44 | 90.6% | |
| 30 Sep. 2025 | $-7.48 | $34.14 | -121.9% | |
| 30 Juni 2025 | $79.40 | $57.15 | 38.9% | |
| 31 Maret 2025 | $-65.35 | $-55.79 | -17.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.51T | $4.58T | $4.26T | $4.03T | $3.57T | $3.20T | $3.29T | $2.10T | $1.77T | |
| Cost of Revenue | $1.57T | $1.58T | $1.43T | $1.24T | $1.11T | $994.31B | $1.09T | $651.73B | $495.92B | |
| R&D Expense | $675.92B | $730.23B | $729.92B | $633.33B | $526.09B | $455.83B | $492.38B | $368.30B | $325.44B | |
| Operating Income | $6.22B | $342.59B | $214.07B | $490.50B | $460.84B | $509.27B | $100.41B | $237.69B | $241.79B | |
| Interest Expense | $148.12B | $137.31B | $119.53B | $116.97B | $122.43B | $130.81B | $149.01B | $48.16B | $10.04B | |
| Interest Income | $211.18B | $46.55B | $52.09B | $62.91B | $23.70B | $105.52B | $27.83B | $16.84B | $39.54B | |
| Pretax Income | $-142.35B | $175.08B | $52.79B | $375.09B | $302.57B | $366.24B | $-60.75B | $127.61B | $217.21B | |
| Income Tax | $9.77B | $66.94B | $-91.41B | $58.05B | $72.41B | $-9.94B | $-105.04B | $-7.47B | $30.50B | |
| Net Income | $-152.39B | $107.93B | $144.07B | $317.02B | $230.06B | $376.00B | $44.24B | $135.19B | $186.89B | |
| EPS (Basic) | $-96.75 | $68.36 | $92.09 | $204.29 | $147.14 | $240.72 | $28.41 | $140.61 | $239.35 | |
| EPS (Diluted) | $-96.75 | $67.23 | $91.16 | $201.94 | $145.87 | $238.96 | $28.25 | $139.82 | $237.56 | |
| Shares (Basic) | 1,575,062,000 | 1,578,873,000 | 1,564,450,000 | 1,551,809,000 | 1,563,501,000 | 1,562,006,000 | 1,557,204,000 | 961,477,000 | 780,812,000 | |
| Shares (Diluted) | 1,575,062,000 | 1,605,323,000 | 1,580,343,000 | 1,569,872,000 | 1,577,169,000 | 1,573,537,000 | 1,566,204,000 | 966,897,000 | 786,707,000 | |
| EBITDA | $727.34B | $1.10T | $942.08B | $1.15T | $1.04T | $1.07T | $684.06B | $477.42B | · |
Neraca
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $144.76B | $233.74B | $205.19B | $229.56B | $389.06B | $335.03B | $188.64B | $462.89B | $243.32B | |
| Receivables | $844.31B | $709.47B | $668.40B | $649.43B | $696.64B | $783.09B | $757.00B | $741.91B | $420.25B | |
| Inventory | $1.40T | $1.22T | $1.21T | $986.46B | $853.17B | $753.88B | $759.60B | $919.67B | $212.94B | |
| Current Assets | $3.09T | $2.52T | $2.56T | $2.40T | $2.59T | $2.71T | $2.47T | $2.99T | $1.08T | |
| PP&E (Net) | · | · | · | $1.69T | $1.58T | $1.45T | $1.39T | $1.33T | $536.80B | |
| Goodwill | $5.81T | $5.32T | $5.41T | $4.79T | $4.41T | $4.03T | $4.01T | $4.24T | $1.03T | |
| Intangibles | $3.42T | $3.63T | $4.27T | $4.27T | $3.82T | $3.91T | $4.17T | $4.75T | $1.01T | |
| Total Assets | $15.51T | $14.25T | $15.11T | $13.96T | $13.18T | $12.91T | $12.82T | $13.79T | $4.11T | |
| Accounts Payable | $491.35B | $475.54B | $547.52B | $649.23B | $516.30B | $343.84B | $318.82B | $327.39B | $240.26B | |
| Current Liabilities | $2.83T | $2.51T | $2.31T | $2.48T | $2.15T | $1.77T | $2.18T | $2.55T | $737.51B | |
| Total Liabilities | $8.08T | $7.31T | $7.83T | $7.60T | $7.49T | $7.74T | $8.09T | $8.61T | $2.09T | |
| Retained Earnings | $712.38B | $1.19T | $1.39T | $1.54T | $1.48T | $1.51T | $1.37T | $1.60T | $1.56T | |
| Stockholders' Equity | $7.43T | $6.94T | $7.27T | $6.35T | $5.68T | $5.17T | $4.72T | $5.18T | $2.00T |
Arus Kas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $721.13B | $761.40B | $728.00B | $664.40B | $583.15B | $559.67B | $583.65B | $247.69B | $182.13B | |
| Other Non-cash | $472.69B | $187.86B | $-155.72B | $-4.26B | $309.89B | $75.25B | $41.86B | $-53.09B | · | |
| Operating Cash Flow | $1.04T | $1.06T | $716.34B | $977.16B | $1.12T | $1.01T | $669.75B | $328.48B | $377.85B | |
| CapEx | $176.00B | $200.79B | $175.42B | $140.66B | $123.25B | $111.21B | $127.08B | $77.68B | $67.00B | |
| Investing Cash Flow | $-369.14B | $-367.06B | $-463.86B | $-607.10B | $-198.12B | $393.53B | $292.12B | $-2.84T | $-93.34B | |
| Dividends Paid | $311.90B | $302.50B | $287.19B | $279.42B | $283.67B | $283.36B | $282.58B | $142.95B | $141.89B | |
| Financing Cash Flow | $-496.82B | $-751.42B | $-354.42B | $-709.15B | $-1.07T | $-1.09T | $-1.01T | $2.95T | $-326.23B | |
| Free Cash Flow | $865.43B | $856.39B | $540.92B | $836.50B | $999.85B | $899.73B | $542.67B | $250.80B | · | |
| Levered FCF | $707.14B | $771.58B | $214.42B | $737.63B | $906.72B | $765.37B | $651.30B | $195.48B | · |
Profitabilitas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 0.14% | 7.5% | 5.0% | 12.2% | 12.9% | 15.9% | 3.0% | 9.8% | · | |
| Net Margin | -3.4% | 2.4% | 3.4% | 7.9% | 6.5% | 11.8% | 1.3% | 5.2% | · | |
| Pretax Margin | -3.2% | 3.8% | 1.2% | 9.3% | 8.5% | 11.5% | -1.8% | 4.5% | · | |
| EBITDA Margin | 16.1% | 24.1% | 22.1% | 28.7% | 29.2% | 33.4% | 20.8% | 22.8% | · | |
| ROA | -1.0% | 0.74% | 0.99% | 2.3% | 1.8% | 2.9% | 0.33% | 1.2% | · | |
| ROE | -2.1% | 1.5% | 2.1% | 5.3% | 4.2% | 7.6% | 0.89% | 3.0% | · | |
| ROIC | 0.09% | 3.0% | 8.0% | 6.5% | 6.2% | 10.1% | -1.6% | 4.6% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.2 | 1.5 | 1.1 | 1.2 | · | |
| Quick Ratio | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.6 | 0.4 | 0.5 | · | |
| Interest Coverage | 0.0 | 2.5 | 1.8 | 4.2 | 3.8 | 3.9 | 0.7 | 4.3 | · |
Efisiensi
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | · | |
| Inventory Turnover | 1.2 | 1.3 | 1.3 | 1.4 | 1.4 | 1.3 | 1.3 | 1.1 | · | |
| Receivables Turnover | 5.8 | 6.7 | 6.5 | 6.0 | 4.8 | 4.2 | 4.4 | 3.6 | · |
Per Saham
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $2860.66 | $2853.97 | $2698.00 | $2565.48 | $2262.92 | $2032.24 | $2101.38 | $2169.03 | · | |
| Cash Flow / Share | $661.20 | $658.55 | $453.28 | $622.44 | $712.10 | $642.46 | $427.63 | $339.72 | · | |
| EPS (TTM) | $-96.75 | $67.23 | $91.16 | $201.94 | $145.87 | $238.96 | $28.25 | $139.82 | · |
Valuasi (TTM)
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.51T | $4.58T | $4.26T | $4.03T | $3.57T | $3.20T | $3.29T | $2.10T | · | |
| Net Income TTM | $-152.39B | $107.93B | $144.07B | $317.02B | $230.06B | $376.00B | $44.24B | $135.19B | · | |
| P/E | -0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.5 | 0.1 | · | |
| Earnings Yield | -522.4% | 452.1% | 656.3% | 1225.4% | 1018.7% | 1308.6% | 186.1% | 686.4% | · | |
| Payout Ratio | -204.7% | 280.3% | 199.3% | 88.1% | 123.3% | 75.4% | 638.7% | 131.0% | · | |
| Annual Payout | $311.90B | $302.50B | $287.19B | $279.42B | $283.67B | $283.36B | $282.58B | $142.95B | · |
Tidak ada pengajuan triwulanan untuk TAK
Kami belum memiliki pengajuan SEC untuk ticker ini.
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Pendapatan | $4.51T | $4.58T | $4.26T | $4.03T | $3.57T |
| Margin Operasi % | 0.14% | 7.5% | 5.0% | 12.2% | 12.9% |
| Laba Bersih | $-152.39B | $107.93B | $144.07B | $317.02B | $230.06B |
| EPS Dilusian | $-96.75 | $67.23 | $91.16 | $201.94 | $145.87 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 1.1 | 1.0 | 1.1 | 1.0 | 1.2 |
| Rasio Cepat | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $865.43B | $856.39B | $540.92B | $836.50B | $999.85B |
Pemilik institusional (13F) 409 pengaju · $1.7B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
409
Nilai yang dipegang
$1.7B
Posisi baru
64
Posisi yang keluar
38
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 64 (0 vs Kuartal sebelumnya) | 38 (+5 vs Kuartal sebelumnya) | 144 (-28 vs Kuartal sebelumnya) | 99 (+41 vs Kuartal sebelumnya) | +6.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Capital Research Global Investors | $309.341.810 | 19.297.680 | 18,23% | Saham |
| FMR LLC | $153.876.803 | 9.599.302 | 9,07% | Saham |
| MORGAN STANLEY | $112.128.655 | 6.994.924 | 6,61% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $96.993.859 | 6.050.771 | 5,71% | Saham |
| GOLDMAN SACHS GROUP INC | $82.154.258 | 5.125.032 | 4,84% | Saham |
| BRANDES INVESTMENT PARTNERS, LP | $72.765.928 | 4.539.347 | 4,29% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $59.838.772 | 3.732.924 | 3,53% | Saham |
| BlackRock, Inc. | $59.121.313 | 3.688.166 | 3,48% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $41.165.040 | 2.568.000 | 2,43% | Saham |
| Qube Research & Technologies Ltd | $35.385.135 | 2.207.432 | 2,08% | Saham |
| FIRST TRUST ADVISORS LP | $33.902.011 | 2.114.912 | 2,00% | Saham |
| D. E. Shaw & Co., Inc. | $32.852.956 | 2.049.467 | 1,94% | Saham |
| MANAGED ASSET PORTFOLIOS, LLC | $29.236.866 | 1.823.884 | 1,72% | Saham |
| NORTHERN TRUST CORP | $27.897.218 | 1.740.313 | 1,64% | Saham |
| VAN ECK ASSOCIATES CORP | $26.834.300 | 1.674.005 | 1,58% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $25.617.763 | 1.598.174 | 1,51% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $24.456.751 | 1.525.686 | 1,44% | Saham |
| Quantinno Capital Management LP | $22.484.494 | 1.402.650 | 1,32% | Saham |
| WELLS FARGO & COMPANY/MN | $18.447.659 | 1.150.820 | 1,09% | Saham |
| MILLENNIUM MANAGEMENT LLC | $16.842.689 | 1.050.698 | 0,99% | Saham |
| UBS Group AG | $14.608.444 | 911.319 | 0,86% | Saham |
| Crossmark Global Holdings, Inc. | $12.564.875 | 783.835 | 0,74% | Saham |
| JANE STREET GROUP, LLC | $12.327.070 | 769.000 | 0,73% | Opsi beli |
| CITADEL ADVISORS LLC | $12.165.167 | 758.900 | 0,72% | Opsi beli |
| JPMORGAN CHASE & CO | $11.903.771 | 744.916 | 0,70% | Saham |
| STIFEL FINANCIAL CORP | $11.587.485 | 722.863 | 0,68% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $11.447.712 | 714.143 | 0,67% | Saham |
| ROYAL BANK OF CANADA | $11.107.000 | 692.900 | 0,65% | Saham |
| Focus Partners Wealth | $10.901.024 | 679.950 | 0,64% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.922.907 | 619.021 | 0,58% | Saham |
| Creative Planning | $9.373.982 | 584.777 | 0,55% | Saham |
| AMERICAN CENTURY COMPANIES INC | $9.370.497 | 584.560 | 0,55% | Saham |
| LPL Financial LLC | $8.900.303 | 555.228 | 0,52% | Saham |
| Balyasny Asset Management L.P. | $8.196.716 | 511.336 | 0,48% | Saham |
| TWO SIGMA INVESTMENTS, LP | $7.786.300 | 485.733 | 0,46% | Saham |
| US BANCORP \DE\ | $7.481.425 | 466.714 | 0,44% | Saham |
| PFM Health Sciences, LP | $7.120.093 | 444.173 | 0,42% | Saham |
| Bleakley Financial Group, LLC | $6.940.285 | 432.956 | 0,41% | Saham |
| RAYMOND JAMES FINANCIAL INC | $6.552.092 | 408.739 | 0,39% | Saham |
| CITIGROUP INC | $6.355.206 | 396.457 | 0,37% | Saham |
| FEDERATED HERMES, INC. | $6.041.034 | 376.858 | 0,36% | Saham |
| QRG CAPITAL MANAGEMENT, INC. | $5.975.215 | 372.752 | 0,35% | Saham |
| Ethic Inc. | $5.854.998 | 365.253 | 0,34% | Saham |
| Vestmark Advisory Solutions, Inc. | $5.638.878 | 351.770 | 0,33% | Saham |
| ASSETMARK, INC | $5.044.432 | 314.687 | 0,30% | Saham |
| Mariner, LLC | $4.939.586 | 308.157 | 0,29% | Saham |
| BANK OF AMERICA CORP /DE/ | $4.926.218 | 307.312 | 0,29% | Saham |
| TWO SIGMA ADVISERS, LP | $4.652.056 | 298.400 | 0,27% | Saham |
| Hudson Bay Capital Management LP | $4.408.250 | 275.000 | 0,26% | Saham |
| Pathstone Holdings, LLC | $3.843.704 | 239.306 | 0,23% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited, Takeda Vaccines Inc. ×9 pengajuan | 19 Sep. 2025 | 0,00% | Amandemen | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 25 orang dalam · 16 pejabat · 11 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Julie So-Young Kim | President and CEO | 10 Agu 2026 S | 391.489 | 0 | 1 | $-1.523.439 |
| Milano Furuta | Chief Financial Officer | 1 Juli 2026 A | 70.200 | 0 | 0 | $0 |
| Andrew Stewart Plump | President, R&D | 2 Sep. 2026 S | 145.465 | 0 | 3 | $-5.339.939 |
| Ramy Riad Ahmed Ibrahim | President, PDT BU | 10 Agu 2026 S | 102.588 | 0 | 1 | $-124.437 |
| Rhonda Janice Pacheco | President, U.S. Business Unit | 10 Agu 2026 S | 182.507 | 0 | 1 | $-289.007 |
| Giles Richard Platford | President, IBU | 10 Agu 2026 S | 315.838 | 0 | 1 | $-531.519 |
| Teresa Marie Bitetti | President, OBU | 10 Agu 2026 S | 252.010 | 0 | 1 | $-855.205 |
| Asuka Miyabashira | President, Japan Pharma B.U. | 1 Juli 2026 A | 4.500 | 0 | 0 | $0 |
| Lauren Rusckowski Duprey | Chief Transformation Officer | 14 Sep. 2026 S | 191.522 | 0 | 2 | $-1.454.000 |
| Nicola Deidre Petal Greenway | Chief Human Resources Officer | 18 Agu 2026 S | 40.049 | 0 | 4 | $-956.791 |
| Awny Samaan Botros Farajallah | Chief Medical Officer | 10 Agu 2026 S | 116.177 | 0 | 1 | $-239.503 |
| Natalie Anne Marie Furney | Global General Counsel | 10 Agu 2026 S | 204.298 | 0 | 1 | $-527.843 |
| Elaine Mary Shannon | Pres., Global Supply & Quality | 10 Agu 2026 S | 63.333 | 0 | 2 | $-425.395 |
| Agosti Marcello Pignagnoli | Head, Strat. & Port. Dev | 10 Agu 2026 S | 176.977 | 0 | 1 | $-392.565 |
| Gabriele Ricci | Chief Data & Tech. Officer | 10 Agu 2026 S | 171.654 | 0 | 1 | $-429.005 |
| Jennifer Marie Smoter | Chief Comm. & Gov. Officer | 1 Juli 2026 A | 18.808 | 0 | 0 | $0 |
| Koichiro Kimura | Direktur | 1 Juli 2026 A | 1.800 | 0 | 0 | $0 |
| Masami Iijima | Direktur | 1 Juli 2026 A | 14.601 | 0 | 0 | $0 |
| Miki Tsusaka | Direktur | 1 Juli 2026 A | 8.200 | 0 | 0 | $0 |
| Kimberly A. Reed | Direktur | 1 Juli 2026 A | 10.400 | 0 | 0 | $0 |
| Paulus Stoffels | Direktur | 1 Juli 2026 A | 3.800 | 0 | 0 | $0 |
| Steven Gillis | Direktur | 1 Juli 2026 A | 10.400 | 0 | 0 | $0 |
| Bruce D Broussard | Direktur | 1 Juli 2026 A | 4.595 | 0 | 0 | $0 |
| John Maraganore | Direktur | 1 Juli 2026 A | 10.400 | 0 | 0 | $0 |
| Christophe Pierre Weber | · | 27 April 2026 A | 418.803 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 3 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
TAK Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 21 analis
BELI
Target median
$22.15
+24,0%
5 23,8%
Beli Kuat
9 42,9%
Beli
7 33,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
3 analis · 2026-09-30Target rata-rata $22.05 +23,5%
← Di bawah semua target
Harga saat ini $17.86
Rendah$21.00
Rata-rata$22.05
Tinggi$23.00
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 20-F diajukan Jun 17, 2026